V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005407 | 290003943 | 1.68 | 110 | null | 2017-07-20 | 2017-07-20 | CVD (Neuroendocrine) | N | N | 290013542 | CAPECITABINE + RT |
| 290005408 | 290003944 | 1.6 | 49.5 | Palliative (P) | 2017-02-15 | 2017-02-15 | Capecitabine | N | N | 290013563 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005409 | 290003945 | 156 | 67.65 | Neo-adjuvant (N) | 2017-06-05 | 2017-06-30 | Cetuximab + Radiotherapy Load | 02 | N | 290013573 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005410 | 290003946 | 1.6 | 74 | Palliative (P) | 2013-03-19 | 2013-03-31 | Carboplatin + Etoposide IV 3 day | Y | N | 290013711 | CARBO + FLUOROURACIL |
| 290005411 | 290003946 | 1.6 | 60.3 | null | 2017-07-24 | 2017-08-18 | CARBOPLATIN | 2 | null | 290013711 | RITUXIMAB |
| 290005412 | 290003947 | 1.75 | 92.3 | Palliative (P) | 2017-08-13 | 2017-08-13 | Cisplatin + Vinorelbine (IV) | N | N | 290013839 | CAPECITABINE |
| 290005413 | 290003948 | 1.84 | 62.1 | Adjuvant (A) | 2016-05-21 | 2016-05-21 | CARBOPLATIN + FLUOROURACIL | N | N | 290014177 | OCTREOTIDE |
| 290005414 | 290003949 | 1.68 | 64 | Curative (C) | 2017-07-22 | 2017-08-11 | LANREOTIDE | 02 | Y | 290014208 | CISPLATIN + ETOPOSIDE |
| 290005415 | 290003950 | null | 72.3 | null | 2019-01-20 | 2019-01-20 | Irinotecan weekly | 02 | N | 290014217 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290005416 | 290003950 | 1.77 | 74.1 | Disease modification (D) | 2015-08-05 | 2015-08-26 | LANREOTIDE | N | N | 290014217 | CAPECITABINE |
| 290005417 | 290003950 | 1.56 | 89.6 | Palliative (P) | 2016-10-08 | 2016-10-12 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 290014217 | CAPECITABINE + RT |
| 290005418 | 290003951 | null | 74 | Neo-adjuvant (N) | 2017-05-07 | 2017-05-29 | Rituximab (Maintenance) | 02 | Y | 290014260 | CAPECITABINE |
| 290005419 | 290003951 | 1.74 | 65 | Palliative (P) | 2016-07-17 | 2016-07-24 | Trial Unspecified | N | N | 290014260 | BENDAMUSTINE + RITUXIMAB |
| 290005420 | 290003952 | null | 100 | Neo-adjuvant (N) | 2014-10-06 | 2014-10-26 | CARBOPLATIN + ETOPOSIDE | N | N | 290014319 | CARBOPLATIN |
| 290005421 | 290003953 | 1.66 | 60.5 | Palliative (P) | 2015-05-18 | 2015-07-11 | ECX | N | N | 290014364 | GEMCITABINE |
| 290005422 | 290003954 | null | 42.8 | Adjuvant (A) | 2017-07-13 | 2017-08-03 | EVEROLIMUS | 02 | N | 290014538 | CETUXIMAB + RT |
| 290005423 | 290003954 | 1.66 | 62 | Palliative (P) | 2018-12-13 | 2018-12-18 | Capecitabine 35days + RT | 02 | N | 290014538 | CAPECITABINE + CISPLATIN |
| 290005424 | 290003955 | 1.72 | 78.6 | Curative (C) | 2019-03-01 | 2019-03-20 | Trial Unspecified | 02 | N | 290014591 | CETUXIMAB + RT |
| 290005425 | 290003956 | null | 88 | Adjuvant (A) | 2017-06-22 | 2017-06-22 | Capecitabine | 2 | N | 290014622 | FLUOROURACIL |
| 290005426 | 290006675 | null | 36.35 | Neo-adjuvant (N) | 2016-11-18 | 2016-11-22 | RCEOP | N | N | 290014651 | CAPECITABINE + RT |
| 290005427 | 290003957 | 1.7 | 68.6 | Palliative (P) | 2018-02-18 | 2018-03-18 | Docetaxel | N | N | 290015003 | CISPLATIN + FLUOROURACIL |
| 290005428 | 290003958 | null | 65 | Palliative (P) | 2016-07-28 | 2016-07-30 | Ipilimumab | Y | N | 290015019 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005429 | 290006676 | 1.1 | 71.5 | Adjuvant (A) | 2016-08-28 | 2016-08-28 | CARBOPLATIN + ETOPOSIDE | 02 | N | 290015077 | CISPLATIN + FLUOROURACIL |
| 290005430 | 290003959 | 1.65 | 70.7 | Palliative (P) | 2017-10-05 | 2017-10-12 | Carboplatin + Etoposide IV 3 day | 02 | N | 290015082 | MCX |
| 290005431 | 290003959 | 1.53 | 73 | Palliative (P) | 2014-01-12 | 2014-01-16 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | 290015082 | CAPECITABINE |
| 290005432 | 290003959 | 1.61 | 67.9 | null | null | 2013-07-08 | CAPECITABINE + CARBOPLATIN | N | N | 290015082 | CISPLATIN + FLUOROURACIL |
| 290005433 | 290003960 | 1.64 | 67 | Curative (C) | 2014-07-13 | 2014-07-23 | Cisplatin + Etoposide (3 day) | N | N | 290015282 | CAPECITABINE |
| 290005434 | 290003961 | 1.54 | 58 | Palliative (P) | 2015-05-17 | 2015-06-13 | CAPECITABINE + TEMOZOLOMIDE | 2 | null | 290015319 | LANREOTIDE |
| 290005435 | 290003962 | null | null | null | 2017-08-15 | 2017-09-04 | OCTREOTIDE | N | null | 290015321 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290005436 | 290003963 | 1.6 | 41.1 | Palliative (P) | 2018-05-05 | 2018-05-25 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 290015351 | CISPLATIN + FLUOROURACIL |
| 290005437 | 290003964 | 1.6 | 78.9 | Neo-adjuvant (N) | 2017-06-06 | 2017-07-04 | Fluorouracil + Folinic Acid Weekly | 02 | Y | 290015419 | CAPECITABINE + RT |
| 290005438 | 290003965 | 1.62 | 60.9 | Palliative (P) | 2017-08-06 | 2017-08-06 | Capecitabine | 02 | N | 290015453 | CARBOPLATIN |
| 290005439 | 290003966 | 1.6 | 38 | Curative (C) | 2016-12-30 | 2017-01-10 | Capecitabine 42days + RT | 2 | null | 290015478 | GEMCITABINE |
| 290005440 | 290003967 | 1.56 | 73.8 | Neo-adjuvant (N) | 2016-02-24 | 2016-03-03 | BENDAMUSTINE + RITUXIMAB | N | N | 290015498 | FLUOROURACIL |
| 290005441 | 290003968 | null | 75 | Palliative (P) | 2018-04-30 | 2018-04-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290015533 | OCTREOTIDE |
| 290005442 | 290003969 | 1.68 | 83 | Palliative (P) | 2017-08-07 | 2017-08-31 | BALLAD Trial | N | N | 290015535 | PAZOPANIB |
| 290005443 | 290003969 | 1.68 | null | Neo-adjuvant (N) | 2017-01-03 | 2017-01-29 | LANREOTIDE | N | N | 290015535 | PEMBROLIZUMAB |
| 290005444 | 290003969 | 1.56 | 54 | Adjuvant (A) | 2017-08-30 | 2017-09-13 | Capecitabine + Cisplatin | N | N | 290015535 | CETUXIMAB + RT |
| 290005445 | 290003970 | 1.77 | 84.3 | Palliative (P) | 2017-05-26 | 2017-07-19 | Carboplatin + Etoposide iv&po | N | N | 290015582 | EOX |
| 290005446 | 290003970 | 1.58 | 53.7 | Curative (C) | 2016-02-02 | 2016-02-18 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 290015582 | GEMCARBO |
| 290005447 | 290003970 | 0 | 91.3 | Palliative (P) | 2016-08-16 | 2016-08-16 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 290015582 | OCTREOTIDE |
| 290005448 | 290003970 | 1.86 | 79.9 | Palliative (P) | 2019-03-05 | 2019-04-06 | Ipilimumab | 02 | N | 290015582 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 290005449 | 290003971 | 1.78 | 82.5 | Palliative (P) | 2017-01-22 | 2017-01-26 | CTD | N | N | 290015867 | CAPECITABINE |
| 290005450 | 290003972 | null | 54.45 | Neo-adjuvant (N) | 2015-12-22 | 2016-01-02 | CETUXIMAB | 2 | Y | 290015910 | EOX |
| 290005451 | 290003973 | 1.81 | 72 | Palliative (P) | 2015-10-29 | 2015-10-30 | CISPLATIN + FLUOROURACIL | 2 | N | 290015924 | CARBO + FLUOROURACIL |
| 290005452 | 290003973 | null | 52.1 | Disease modification (D) | 2018-12-30 | 2019-01-02 | Y-90 | null | N | 290015924 | CAPECITABINE + CARBOPLATIN |
| 290005453 | 290003974 | null | null | Neo-adjuvant (N) | 2015-12-31 | 2015-12-31 | Carboplatin AUC 2 - 5 | 2 | N | 290016172 | CAPECITABINE |
| 290005454 | 290003974 | 1.66 | 120 | Neo-adjuvant (N) | 2015-03-15 | 2015-03-15 | Cisplatin +Fluorouracil (3 wk) | N | N | 290016172 | CAPECITABINE + RT |
| 290005455 | 290003974 | 1.67 | 59 | Palliative (P) | 2014-07-07 | 2014-07-21 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 290016172 | MCX |
| 290005456 | 290003974 | 1.58 | 87 | Palliative (P) | 2019-02-25 | 2019-03-03 | EOX | N | N | 290016172 | CARBOPLATIN + ETOPOSIDE |